Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: Which method should be used?

被引：18

作者：

Degertekin, Bulent ^{[1
]}

Lok, Anna S. ^{[1
]}

机构：

[1] Univ Michigan Hlth Syst, Div Gastroenterol, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF HEPATOLOGY | 2008年 / 48卷 / 06期

关键词：

D O I：

10.1016/j.jhep.2008.03.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：892 / 894

页数：3

相关论文

共 31 条

[1]

Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine [J].

Allen, MI ;

Gauthier, J ;

DesLauriers, M ;

Bourne, EJ ;

Carrick, KM ;

Baldanti, F ;

Ross, LL ;

Lutz, MW ;

Condreay, LD .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) :3338-3347

[2]

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response [J].

Baldick, Carl J. ;

Eggers, Betsy J. ;

Fang, Jie ;

Levine, Steven M. ;

Pokornowski, Kevin A. ;

Rose, Ronald E. ;

Yu, Cheng-Fang ;

Tenney, Daniel J. ;

Colonno, Richard J. .

JOURNAL OF HEPATOLOGY, 2008, 48 (06) :895-902

[3]

Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials [J].

Borroto-Esoda, Katyna ;

Miller, Michael D. ;

Arterburn, Sarah .

JOURNAL OF HEPATOLOGY, 2007, 47 (04) :492-498

[4]

YSDD:: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine [J].

Bozdayi, AM ;

Uzunalimoglu, Ö ;

Türkyilmaz, AR ;

Aslan, N ;

Sezgin, O ;

Sahin, T ;

Bozdayi, G ;

Çinar, K ;

Pai, SB ;

Pai, R ;

Bozkaya, H ;

Karayalçin, S ;

Yurdaydin, C ;

Schinazi, RF .

JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) :256-265

[5]

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J].

Chang, TT ;

Gish, RG ;

de Man, R ;

Gadano, A ;

Sollano, J ;

Chao, YC ;

Lok, AS ;

Han, KH ;

Goodman, Z ;

Zhu, J ;

Cross, A ;

DeHertogh, D ;

Wilber, R ;

Colonno, R ;

Apelian, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1001-1010

[6]

Four year assessment of ETV resistance in nucleoside-naive and lamivudine refractory patients [J].

Colonno, R. J. ;

Rose, R. E. ;

Pokornowski, K. ;

Baldick, C. J. ;

Eggers, B. ;

Yu, D. ;

Cross, A. ;

Tenney, D. J. .

JOURNAL OF HEPATOLOGY, 2007, 46 :S294-S294

[7]

Entecavir resistance is rare in nucleoside naive patients with hepatitis B [J].

Colonno, Richard J. ;

Rose, Ronald ;

Baldick, Carl J. ;

Levine, Steven ;

Pokornowski, Kevin ;

Yu, Cheng F. ;

Walsh, Ann ;

Fang, Jie ;

Hsu, Mayla ;

Mazzucco, Charles ;

Eggers, Betsy ;

Zhang, Sharon ;

Plym, Mary ;

Klesczewski, Kenneth ;

Tenney, Daniel J. .

HEPATOLOGY, 2006, 44 (06) :1656-1665

[8]

Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir [J].

Curtis, Maria ;

Zhu, Yuao ;

Borroto-Esoda, Katyna .

JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (10) :1483-1486

[9]

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus [J].

Delaney, WE ;

Ray, AS ;

Yang, HL ;

Qi, XP ;

Xiong, S ;

Zhu, YA ;

Miller, MD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2471-2477

[10]

Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

← 1 2 3 4 →